| Ofatumumab |
 |
2020-06 |
New use of the anti-CD20 monoclonal antibody (approved for leukemia as Arzerra for IV infusion) as a monthly subcutaneous injection self-administered by autoinjector pen for treatment of adults with relapsing forms of multiple sclerosis (RMS) |
| Adlarity (donepezil, transdermal) |
 |
2020-07-30 |
Once-weekly transdermal patch formulation of the cholinesterase inhibitor using Corium’s Corplex technology for treatment of dementia of the Alzheimer’s type in patients with mild, moderate and severe Alzheimer’s disease |
| Opicapone* |
 |
2020-04-26 |
Selective catechol-O-methyltransferase (COMT) inhibitor as once-daily oral adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease experiencing OFF episodes |
| APL-130277 (apomorphine sublingual film) |
 |
2020-05-21 |
Sublingual film formulation of the dopamine agonist using Aquestive’s PharmFilm technology for on-demand treatment of motor fluctuations (‘off’ episodes) in Parkinson’s disease (PD) patients |
| Risdiplam* |
 |
2020-05-24 |
Survival motor neuron-2 (SMN-2) splicing modifier formulated as an oral liquid for treatment of spinal muscular atrophy (SMA) |
